strategy to develop microemulsion based in situ nasal gel (MEG) to entrap Lorazepam (BCS II) for the treatment of various CNS diseases using Capmul MCM-in water media. The interaction ... with Carbopol in water was…
channel blocker is used in the treatment of hypertension. Nisoldipine belongs to BCS Class II drug which is poorly soluble in water and have very less bioavailability (5%). SNEDDS ... highest solubility. Various…
phase III human clinical trial for heart failure and improved cardiac function in a phase II patient study. These findings could support the development clinical studies using NRG-1 alone
delbrueckii 490, as well as the environmental isolate (from sugar beet pulp) Lactobacillus plantarum II. Aerobic cultivation of lactic acid bacteria was conducted at 37Ã ... spectrophotometry using Assay Kits…
biologically inactive derivative of gliclazide, a sulphonyl urea analogue used to treat type II diabetes mellitus. A rapid liquid chromatography tandem mass spectrometry LCMS-MS method has been optimized…
acivities. The main mechanism is phosphorylation of MAPKs and activation of Keap1, Nrf2 and phase II detoxification enzymes. The acute and subacute toxicity was measured to prove the primary safety
ecology have been studied. Since some of these breeds are still in the formulation phase, their younger ones differ little from each other and form transitional forms (Rosa, Malus, Rubus ... practical significance…
limits of their first generation. In this effort, our group recently completed a phase I/II trial in prostate and renal cancer patients with GX301, a new generation cancer vaccine ... efficiently activate both innate…
should not rule out the involvement of others process of detoxification of Phase I or II. In the TCBZ-R strains, the GST, GPx and GSR activity is higher than
therapeutic benefit. SFN is abundant in cruciferous vegetables and is a potent inducer of phase II detoxification in the liver. It is also a biological antioxidant and induces the expression
efficient biosorbent in Pb(II) removal [4], was investigated as a potential biosorbent for the removal of As(V) ions in aqueous phase. The As(V) removal capacity
participates in over 7% of all global Phase III and 3.2% of all global Phase II trials. Further, India is set to grab clinical trials business valued at approximately
from abroad. BCG, a biologic agent, has also stimulated interest and current trials. Phase I-II studies with intravesical interferon have been initiated. While the potential role for intravesical therapy
oligonucleotides to screen for mutations and single nucleotide polymorphisms in genes of phase I, phase II, transporters, receptors and other enzymes and proteins with which drugs interact aft er entering
human adult and infants. The immunogenicity of the vaccine has been studied in Phase I/II safety-immunogenicity trial. Results: Virus titers for all serotypes are adequate enough to formulate
construct facilities to make enough material to test in animals or even in phase-II human clinical trials. If scale-up ultimately requires large fixed facilities. The development of robust
violation. Design structure of the proposed control chart is developed and its performance of phase II monitoring is compared with the competing control charts. The run length comparisons reveal that
trials has been the RTS, S/AS02A, the first vaccine to pass through the phase-II clinical trials. The polymorphic nature of AMA1 and some other malaria vaccine candidates such
safe, highly immunogenic and easy to be manufactured on a large scale basis. Phase-II studies are ongoing to evaluate efficacy of these novel genetic vaccines
vaccine candidate should be established prior to initiation of a clinical phase study. Genetic instability of the genes or transgenes within a vaccine may lead to inconsistent expression of complementing ... also…
muscle regeneration being tested in Phase III clinical trials of muscular dystrophy, ischemic cardiomyopathy, Phase II trial of cancer, and Phase I trial of Type II diabetes. Differentiated and committed
infected patients under successful cART) called retroseroconversion. BIOSANTECH was the sponsor of a phase I/II clinical trial carried out at Marseille on 48 HIV infected volunteers under cART with
candidate CV638 is under development in Cuba. It has satisfactorily passed phase 0, phase I and II in adults. Thus, a randomized, placebo controlled, phase I clinical trial was conducted
vaccine began in 1995. From then up to now, 6 proof of principle (Phase I-II) clinical trials demonstrated the immunogenicity, safety and preliminary evidences of effect in survival ... select the product formulation…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.